Jul. JelloX Biotech Collaborates with Mayo Clinic to Develop AI Enhanced 3D Pathology Imaging Technology

Jun.  Invited presentation at BIO- Digital Healthcare: Next Generation Intelligent Pathology Driven by 3D Imaging and AI including international collaboration with Mayo Clinic (recommended by Taiwan Bio Industry Organization) (USA)

May  Invited presentation- Next Generation Intelligent Pathology Driven by 3D Imaging and AI + FL (recommended by Taiwan Society of Personalized Medicine, TSPM)

Jun.  Invited presentation at BIO- Digital Healthcare: Next Generation Intelligent Pathology Driven by 3D Imaging and AI including international collaboration with Mayo Clinic (recommended by Taiwan Bio Industry Organization) (USA)

May  Invited presentation- Next Generation Intelligent Pathology Driven by 3D Imaging and AI + FL (recommended by Taiwan Society of Personalized Medicine, TSPM)

May  Invited presentation- 3D Pathology-inspired Intelligent Healthcare in NTUH Intelligent Healthcare Innovation and Technology Forum (recommended by NTUH-Hsinchu Branch)

May  Recommended by Mayo Clinic Chief Digital Innovation Officer in keynote speech of 10^th Digital Pathology and AI Conference 2024 (USA)

Apr. Publication in Roche Tucson Symposium- High Biopsy Sampling Rate 3D Pathology for Exploring Biomarker Heterogeneity in Cancer Tissues (USA, recommended by Roche Diagnostics)

Mar. Top 10 Global Startup- Mayo Clinic MedTech Accelerator

Jan. Publication in BMC Cancer- A novel computer-assisted tool for 3D imaging of programmed death-ligand 1 expression in immunofluorescence-stained and optically cleared breast cancer specimens

Jan. Top 8 Biomedical Startup- Taiwan x Berkeley Public Health Program

Jan. The 1^st TFDA SaMD Approval- MetaLite DX Digital Pathology Software

Dec. Establishment of digital pathology system in Malaysia medical institutes in collaboration with Intel

Nov. Exhibition in Intel Innovation as an ecosystem innovator of digital pathology with AI on PC

Nov. Publication in ICBBE 2023- Stain-composition augmentation facilitates cross-staining and inter-institutional generalizability of federated learning in computational pathology (Japan)

Oct. Publication in ESMO 2023- Comprehensive diagnosis of PD-L1 from 2D to 3D in breast cancer with AI system (Spain)

Oct. Top 3-Berkeley SkyDeck Accelerator

Sep. TFDA approval- Medical Device Quality Management System

Sep. Publication in Laboratory Investigation- Panoramic tissue examination that integrates 3-dimensional pathology imaging and gene mutation: Potential utility in non-small cell lung cancer

May. Top 10 Award- Healthcare of Select USA Investment Summit (Recommended by Ministry of Economic Affairs)

Apr. Invited presentation- Next Generation Pathology for Precision Healthcare in Intel Vision as an ecosystem innovator (Recommended by Intel)

Jan. Publication in Heliyon- Deep-learning based breast cancer detection for cross-staining histopathology images

Dec. FDA ISO13485:2016 Certificate

Dec. H. Spectrum⁺ Rising Star Award

Dec. Intel-Roche Diagnostic Taiwan-JelloX Biotech forming Digital Pathology Industry Alliance to promote next generation pathology

Nov. JelloX Biotech CEO Yen-Yin Lin won the third prize of 2022 Best Bio Startup CEO

Oct.  Publication in Frontiers in Oncology- A domain knowledge enhanced yield based deep learning classifier identifies perineural invasion in oral cavity squamous cell carcinoma

Oct.  Precision diagnosis of nerve invasion in oral cancer with Domain-KEY AI model

Oct. JelloX Biotech is recommended by Hsinchu Biomedical Science Park to share new business opportunities in next generation digital pathology total solution

Oct. JelloX Biotech is awarded as new members of H. Spectrum Accelerator sponsored by Foxconn Technology Co.,Ltd.  Deeper collaboration in domestic resources and international ecosystem is ongoing

Sep. Exhibition in Intel Innovation @ USA as APAC digital health representative

Sep.  Oral presentation of precision medicine session in Taiwan-Japan Science and Technology Forum

Sep. Publication in ECP2022-3D biomarker expression and genetic alterations in NSCLC

Sep. Publication in ECP2022-3D diagnosis of HER2 expression-low breast cancers

Aug. Publication in J. Histochemistry & Cytochemistry 2022-Prostate cancer 3D morphology and Gleason scoring

Apr. Publication in J. Translational Medicine-Lung cancer 3D PD-L1 profiling and TPS evaluation

Apr.  Recognition as Intel Market Ready Solution

Apr. TW patent issued-I761016

Mar. Get DUNS Registered™ Certificate

Mar. Boehringer Ingelheim’s Grass Roots Initiative Award

Jan. Deep-learning based breast cancer detection for cross-staining histopathology images

Jan. TW patent issued-I753521

Jan. TW patent issued-I753448